Syndax Announces Participation in May Investor Conferences

Rhea-AI Summary

Syndax Pharmaceuticals (NASDAQ: SNDX), a commercial-stage biopharmaceutical company focused on innovative cancer therapies, has announced its participation in two upcoming investor conferences in May 2025. CEO Michael A. Metzger and the management team will present at:

- The Bank of America Merrill Lynch Vegas Health Care Conference on May 15, 2025, at 12:20 p.m. ET

- The TD Cowen 6th Annual Oncology Innovation Summit on May 28, 2025, at 10:30 a.m. ET

Both presentations will be available via webcast on the company's website at www.syndax.com.

NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that Michael A. Metzger, Chief Executive Officer of Syndax, as well as members of the Syndax management team, will participate in the following upcoming investor conferences:

• Bank of America Merrill Lynch Vegas Health Care Conference with a fireside chat on Thursday, May 15, 2025, at 9:20 a.m. PT/ 12:20 p.m. ET.
• TD Cowen 6^th Annual Oncology Innovation Summit with a virtual fireside chat on Wednesday, May 28, 2025, at 10:30 a.m. ET.

A live webcast of the fireside chats will be available in the Investor section of the Company's website at www.syndax.com, where a replay will also be available for a limited time.

About Syndax

Syndax Pharmaceuticals is a commercial-stage biopharmaceutical company advancing innovative cancer therapies. Highlights of the Company's pipeline include Revuforj^® (revumenib), an FDA-approved menin inhibitor, and Niktimvo™ (axatilimab-csfr), an FDA-approved monoclonal antibody that blocks the colony stimulating factor 1 (CSF-1) receptor. Fueled by our commitment to reimagining cancer care, Syndax is working to unlock the full potential of its pipeline and is conducting several clinical trials across the continuum of treatment. For more information, please visit www.syndax.com or follow the Company on X and LinkedIn.

Syndax Contacts
Sharon Klahre
Syndax Pharmaceuticals, Inc.
sklahre@syndax.com
Tel 781.684.9827

SNDX-G

FAQ

When is Syndax Pharmaceuticals (SNDX) presenting at the Bank of America Healthcare Conference in May 2025?

Syndax Pharmaceuticals will present at the Bank of America Merrill Lynch Vegas Health Care Conference on Thursday, May 15, 2025, at 12:20 p.m. ET (9:20 a.m. PT).

What investor conferences is Syndax Pharmaceuticals (SNDX) attending in May 2025?

Syndax Pharmaceuticals is attending two conferences: the Bank of America Merrill Lynch Vegas Health Care Conference on May 15 and the TD Cowen 6th Annual Oncology Innovation Summit on May 28, 2025.

Who will be representing Syndax Pharmaceuticals (SNDX) at the May 2025 investor conferences?

Michael A. Metzger, CEO of Syndax Pharmaceuticals, along with members of the Syndax management team, will represent the company at the conferences.

Where can investors watch Syndax Pharmaceuticals' (SNDX) conference presentations?

Live webcasts and replays of the presentations will be available in the Investor section of Syndax's website at www.syndax.com.